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Introduction
Smoking is a risk factor for various diseases such as malig-
nant tumor and respiratory illness, and is one of the most 
important coronary risk factors [1–5]. Some studies have 
reported that the amount of cigarette smoking is related 
to coronary arteriosclerosis [6–9] and is associated with 
an increased risk of the onset of coronary artery disease 
(CAD) [10–13]. Therefore, smoking cessation is being 
actively promoted worldwide. However, the incidence of 
smokers in Japan as of 2012 is still 20.7 %, which is higher 
than in many other countries [14]. Thus, we believe that 
it is important to study the relationship between smoking 
and the severity of coronary arteriosclerosis in the Japa-
nese population. Coronary computed tomography angiog-
raphy (CTA) has become more widely available in many 
general hospitals and emerged as a potential non-invasive 
method for predicting CAD. Few studies have investigated 
the association between smoking habits and the severity of 
coronary atherosclerosis as assessed by CTA in Japan. One 
study investigated the relationship between the amount of 
cigarette smoking and coronary arteriosclerosis by CTA 
in asymptomatic individuals [9]. They reported a ciga-
rette dose–response relationship between current smoking 
and coronary arteriosclerosis in asymptomatic individuals. 
However, this report did not include symptomatic individu-
als or those who were clinically suspected of having CAD. 
Furthermore, the relationship between the duration of ces-
sation and the severity of coronary arteriosclerosis was 
unknown. We hypothesized that the duration of cessation 
Abstract Smoking promotes arteriosclerosis and is one 
of the most important coronary risk factors. However, few 
studies have investigated the association between smoking 
habits and the severity of coronary stenosis as assessed by 
coronary computed tomography angiography (CTA). We 
enrolled 416 patients [165/251 = smoker (past and cur-
rent)/non-smoker)]. They had all undergone CTA and either 
were clinically suspected of having coronary artery disease 
(CAD) or had at least one cardiovascular risk factor. We 
divided the patients into smoking and non-smoking groups, 
and evaluated the presence of CAD, the number of signifi-
cantly stenosed coronary vessels (VD), and the Gensini 
score as assessed by CTA in the two groups. The incidence 
of CAD, VD, the Gensini score, and coronary calcification 
score in the smoking group were all significantly greater 
than those in the non-smoking group (CAD, p = 0.009; 
VD, p = 0.003; Gensini score, p = 0.007; coronary calcifi-
cation score, p = 0.01). Pack-year was significantly associ-
ated with VD and the Gensini score, and was strongly asso-
ciated with multi-vessel disease (2- and 3-VD) (p < 0.05), 
whereas the duration of cessation in past smokers was not 
associated with VD or the Gensini score. Pack-year, but not 
the duration of cessation, may be the most important factor 
that was associated with the severity of coronary stenosis in 
terms of VD and the Gensini score.
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in addition to the amount of cigarette smoking could be 
associated with the severity of coronary arteriosclerosis. 
Therefore, we enrolled patients who had undergone CTA 
and who either were clinically suspected of having CAD or 
had at least one cardiovascular risk factor, and investigated 
the association between smoking habits (amount of ciga-
rette smoking and duration of cessation) and the severity of 
coronary stenosis as assessed by CTA.
Methods
Subjects
We enrolled a total of 416 consecutive patients who under-
went CTA from April 2012 to June 2014 and were clini-
cally suspected of having CAD based on abnormal findings 
by electrocardiography and/or chest symptoms (such as 
chest pain or chest discomfort) or had at least one cardio-
vascular risk factor [smoking, abdominal obesity, dyslipi-
demia (DL), hypertension (HTN), and/or diabetes mellitus 
(DM)]. Patients in whom we could not evaluate coronary 
stenosis due to severe calcification, or who had acute coro-
nary syndrome, Kawasaki disease or Marfan syndrome, 
were excluded. The protocol in this study was approved 
by the ethics committee of Fukuoka University Hospital 
[IRB #11-06(09-089)], and all subjects gave their written 
informed consent to participate.
Evaluation of coronary stenosis using CTA
We evaluated coronary stenosis using multi detector-row 
computed tomography (MDCT) as previously described 
[15]. Three hundred seventeen patients who had undergone 
MDCT from April 2012 to January 2014 were scanned by 
64-MDCT on an Aquilion 64 (TOSHIBA, Tokyo, Japan), 
and 99 patients who had undergone MDCT from Febru-
ary 2014 to June 2014 were scanned by 320-MDCT on an 
Aquilion ONE ViSION (TOSHIBA, Tokyo, Japan). All seg-
ments were assessed according to the 15-segment Ameri-
can Heart Association (AHA) coronary artery model [16]. 
Any narrowing of the normal contrast-enhanced lumen on 
coronary artery ≥50 % that could be identified in multiple 
reconstructions or cross-sectional images was analyzed. 
Lumen diameter stenosis ≥50 % was defined as significant 
coronary stenosis.
Evaluation of patient characteristics 
including biochemical parameters
Data regarding age, gender, body mass index (BMI), smok-
ing status (current and past smoker and non-smoker), medi-
cation use, systolic blood pressure (SBP), diastolic BP 
(DBP), heart rate (HR), left ventricular ejection fraction 
(LVEF), serum levels of triglycerides (TG), high-density 
lipoprotein cholesterol (HDL-C), low-density lipoprotein-
cholesterol (LDL-C), uric acid (UA), hemoglobin A1c 
(HbA1c) and random plasma glucose (BS), estimated glo-
merular filtration rate (eGFR), high sensitivity C reactive 
protein (hs-CRP), and pentraxin-3 (PTX-3) were collected 
in all patients. The number of pack-years was calculated as 
[packs (where 1 pack consists of 20 cigarettes) smoked per 
day × years as a smoker]. BP was determined as the mean of 
two measurements obtained in an office setting by the con-
ventional cuff method using a mercury sphygmomanometer 
after at least 5 min of rest. The characteristics of the patients 
with regard to history of HTN, DL, and DM were obtained 
from medical records. Patients who had a current SBP 
≥140 mmHg and/or DBP ≥90 mmHg or who were receiv-
ing antihypertensive therapy were considered to have HTN. 
Patients with LDL-C ≥140 mg/dl, TG ≥150 mg/dl, and/or 
HDL-C <40 mg/dl, or who were receiving lipid-lowering 
therapy were considered to have DL. Patients with random 
BG ≥200 mg, fasting BG ≥126 mg, and/or HbA1c ≥6.5 %, 
or who were taking a glucose-lowering drug were considered 
to have DM. Hyperuricemia (HU) was defined as a serum 
UA level of ≥7.0 mg/dl or the administration of uric acid-
lowering drugs. In all subjects, we also measured the visceral 
fat area (VFA) and subcutaneous fat area (SFA) as assessed 
by CT, and waist circumference (WC) as components of 
metabolic syndrome (MetS). Chronic kidney disease (CKD) 
was defined as an eGFR level <60 ml/min/1.73 m2.
Statistical analysis
Statistical analysis was performed using the Stat View sta-
tistical software package (Stat View 5; SAS Institute Inc., 
Cary, NC, USA). Data are expressed as the mean ± standard 
deviation (SD). The significance of differences was evalu-
ated using the unpaired and paired t test for continuous vari-
ables and the χ2 test for non-continuous variables. Since the 
variables of number of significant stenosed coronary ves-
sels (VD), coronary calcification score, and Gensini score 
(Table 3) did not show a normal distribution expressed as a 
median value and interquartile range, we performed a Mann–
Whitney U test. The Spearman Rank Correlation Coefficient 
was used to evaluate associations between the groups. We 
used a multiple logistic regression analysis for the multi-
variate analysis to evaluate independent predictors for multi-
vessel disease and selected age (≥65 years), gender, BMI 
(>25 kg/m2), HTN, DM, and DL in addition to pack-year 
as independent variables. A receiver operating characteristic 
(ROC) curve analysis was used to determine the cut-off val-
ues of pack-year for distinguishing between no- or 1-VD and 
multi-vessel disease at the highest possible sensitivity and 
specificity. A value of p < 0.05 was considered significant.
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Results
Patient characteristics including biochemical 
parameters
Tables 1 and 2 show the patient characteristics in all 
patients and the smoking and non-smoking groups. The 
smoking group showed significantly higher percentages of 
males and DM, and higher levels of DBP, VFA, TG, BS, 
HbA1c, and UA, and significantly lower levels of SFA, 
LDL-C, and HDL-C than the non-smoking group. Table 3 
shows the severity of coronary arteriosclerosis [percentage 
of CAD, VD, percentage of multi-vessel disease (2- and 
3-VD), calcification score and Gensini score] in the smok-
ing and non-smoking groups. The smoking group showed 
significantly higher percentages of CAD, multi-vessel dis-
ease, a higher Gensini score, and a higher coronary calci-
fication score than those in the non-smoking group (CAD, 
p = 0.009; multi-vessel disease, p = 0.0004; Gensini score, 
p = 0.007; coronary calcification score, p = 0.01).  
Association between smoking habits and inflammatory 
markers (hs‑CRP and PTX‑3)
We also investigated the association between smoking 
habits and inflammatory markers (hs-CRP and PTX-3) 
(Fig. 1). The current smoker group showed significantly 
lower levels of PTX-3 than the past smoker (p = 0.008), 
never smoker (p = 0.03), and never smoker + past smoker 
(p = 0.012) groups (Fig. 1a), whereas there were no sig-
nificant differences in the levels of hs-CRP among groups 
(Fig. 1b). Pack-year was not significantly correlated with 
hs-CRP or PTX-3 (data not shown).
Association between pack‑year or cessation and severity 
of coronary stenosis
We investigated the association between smoking hab-
its (pack-year and duration of cessation) and the severity 
of coronary stenosis in the smoking group. Pack-year and 
duration of cessation were 40 (20–60) packs × years and 4 
(0–14) years, respectively. Pack-year and the Gensini score 
showed a weak positive correlation (r = 0.193, p = 0.013), 
whereas the duration of cessation in past smokers was not 
significantly correlated with the Gensini score (p = 0.944) 
(Fig. 2). In addition, pack-year was significantly associ-
ated with VD (p for trend 0.008) and multi-vessel disease 
(p < 0.05) (Fig. 3a, b), whereas the duration of cessation in 
past smokers was not associated with VD or multi-vessel dis-
ease (Fig. 3c, d). Furthermore, we divided past smokers into 
short duration of cessation (<10 years) and long duration 
of cessation (<20 years) groups. There were no significant 
differences in the severity of coronary stenosis between the 
groups (data not shown). We also investigated the associa-
tion between duration of cessation and the severity of coro-
nary stenosis in the smoking group (current and past smok-
ers). The duration of cessation in the smoking group was not 
associated with VD or multi-vessel disease (data not shown). 
Predictors of multi‑vessel disease in all patients
Next, we analyzed the predictors of multi-vessel disease in 
all patients using independent variables by a logistic regres-
sion analysis (Table 4). We selected pack-year in addition 
to conventional coronary risk factors [age (≥65 years), 
gender (male), BMI (≥25 kg/m2), HTN, DL, and DM] as 
independent variables. HTN (p = 0.0003), DL (p = 0.027), 
DM (p = 0.008), gender (p = 0.0005), age (p = 0.025), 
and pack-year (OR 1.01, p = 0.037) were identified as 
Table 1  Patient characteristics in all patients and the smoking and 
non-smoking groups
BMI body mass index, HTN hypertension, DL dyslipidemia, DM 
diabetes mellitus, HU hyperuricemia, CKD chronic kidney disease, 
ARB angiotensin II receptor blocker, ACE-I angiotensin-converting 
enzyme inhibitor, CCB calcium channel blocker, EPA eicosapentae-
noic acid, SU sulfonylurea and DPP4-I dipeptidyl peptidase-4 inhibi-
tor
* p < 0.05 vs. non-smoking
All (n = 416) Smoking 
(n = 165)
Non-smoking 
(n = 251)
Age (years) 65.4 ± 12.1 64.0 ± 11.3 66.3 ± 12.5
Male, n (%) 215 (51.6) 138 (64)* 77 (36)
BMI (kg/m2) 23.9 ± 3.6 24.3 ± 3.6 23.7 ± 3.5
HTN, n (%) 294 (70.6) 124 (75.1) 170 (67.7)
DL, n (%) 271 (65.4) 111 (67.2) 160 (64.2)
DM, n (%) 95 (22.8) 51 (30)* 44 (17.5)
HU, n (%) 57(13.8) 28 (17) 29 (11.9)
CKD, n (%) 59 (14.1) 20 (12.1) 39 (15.5)
Medication
 ARB, n (%) 158 (38) 64 (39) 94 (37)
 ACE-I, n (%) 12 (2.8) 6 (3.6) 6 (2.3)
 β-blocker, n (%) 45 (10) 20 (12) 25 (9)
 CCB, n (%) 150 (36) 56 (34) 94 (37)
 Diuretic, n (%) 42 (10) 16 (8) 26 (10)
 Statin, n (%) 142 (34) 53 (32) 89 (35)
 EPA, n (%) 10 (2) 4 (2) 6 (2)
 SU, n (%) 30 (7) 17 (10) 13 (5)
 Biguanide, n (%) 29 (6) 16 (9) 13 (5)
 DPP4-I, n (%) 44 (10) 22 (13) 22 (8)
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significant independent variables that predicted multi-ves-
sel disease.
We also defined the cut-off value of pack-year for 
multi-vessel disease. The cut-off level for pack-year with 
the greatest sensitivity and specificity for the presence of 
multi-vessel disease was 26.25 (sensitivity 0.438, speci-
ficity 0.841) by ROC curve analysis. Finally, we divided 
the patients in the smoking group into heavy pack-year 
≥26.25) and light smokers (pack-year <26.25) using this 
cut-off value for pack-year. Multi-vessel disease was 
strongly and independently associated with pack-year 
(p = 0.009) in addition to HTN and DL (Table 5).
Discussion
We demonstrated that smoking habits were significantly 
associated with the severity of coronary stenosis as 
assessed by CTA. The most important finding in this study 
was that the amount of cigarette smoking (pack-year), but 
not the duration of cessation, was the most important fac-
tor associated with the severity of coronary stenosis. Next, 
multi-vessel disease was independently associated with 
pack-year in addition to HTN, DL, DM, age and gender.
Table 2  Various hemodynamic and biochemical parameters in all 
patients and the smoking and non-smoking groups
SBP systolic blood pressure, DBP diastolic BP, HR heart rate, LVEF 
left ventricular ejection fraction, WC waist circumference, VFA vis-
ceral fat area, SFA subcutaneous fat area, eGFR estimated glomerular 
filtration rate, TG triglyceride, LDL-C low-density lipoprotein choles-
terol, HDL-C high-density lipoprotein cholesterol, BS fasting blood 
glucose, HbA1c hemoglobin A1c and UA uric acid
* p < 0.05 vs. non-smoking group
All Smoking Non-smoking
SBP (mmHg) 137 ± 20 137.4 ± 17.1 135.5 ± 19.6
DBP (mmHg) 79.2 ± 12.8 79.2 ± 12.8* 75.6 ± 12.4
HR (min−1) 75 ± 12 72.8 ± 13.5 74.7 ± 13.1
LVEF (%) 70 ± 11 68.3 ± 9.7 69.7 ± 9.9
WC (cm) 84 ± 10 88 ± 9 86 ± 9
SFA (cm2) 138 ± 78 134 ± 67* 165 ± 7
VFA (cm2) 99 ± 62 128 ± 64* 105 ± 51
eGFR (ml/min) 72 ± 24 68 ± 16 68 ± 19
TG (mg/dl) 138 ± 84 156 ± 107* 124 ± 63
LDL-C (mg/dl) 113 ± 33 108 ± 29* 115 ± 32
HDL-C (mg/dl) 52 ± 13 51 ± 15* 56 ± 15
BS (mg/dl) 112 ± 38 114 ± 32* 106 ± 28
HbA1c (%) 6.0 ± 0.7 6.1 ± 1.0* 5.9 ± 0.9
UA (mg/dl) 5.4 ± 1.2 5.7 ± 1.2* 5.1 ± 1.2
Table 3  Assessment of severity 
of coronary atherosclerosis in 
the smoking and non-smoking 
groups
CAD coronary artery disease, VD the number of significant stenosed coronary vessels
Smoking Non-smoking p value smoking vs. non-smoking
CAD (%) 101 (61) 121 (48) 0.009
VD (vessels) 1 (0–2) 0 (0–1) 0.003
Multi-vessel disease (%) 69 (42) 62 (25) 0.0004
Coronary calcification score 27.7 (0–213.4) 2.78 (0–123.1) 0.01
Gensini score 11.5 (4–18.5) 6.25 (1.5–15.4) 0.007
Fig. 1  Associations between smoking habits and inflammatory mark-
ers [PTX-3 (a) and hs-CRP (b)]. N.S. not significant. *p < 0.05 vs. 
current smoker
Many studies have shown that the amount of cigarette 
smoking is associated with vascular disease. Although 
current smoking of >20 cigarettes/day increased the risk 
of CAD among middle-aged hypertensive men in a pro-
spective study in Japan [17], the total amount of ciga-
rette smoking in their life was unknown. Therefore, in 
this study, we replaced the amount of cigarette smoking 
with pack-year and investigated the association between 
the dose–response of smoking and the severity of coro-
nary arteriosclerosis. One study investigated the relation-
ship between the amount of cigarette smoking and coro-
nary atherosclerosis by coronary CTA in asymptomatic 
individuals [9]. The results showed that the prevalence 
of coronary arteriosclerosis in current smokers of more 
than 20 pack-years was significantly higher than that 
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in never smokers. In this study, we investigated another 
very important factor: the association between the dura-
tion of cessation and coronary arteriosclerosis. Our study 
showed that the duration of cessation in past smokers was 
not associated with the severity of coronary arteriosclero-
sis. Some studies have reported that smoking cessation is 
associated with a decrease in the onset rate of CAD [18–
22]. A case–control study in Italy showed that there was 
a substantial drop in the risk of acute myocardial infarc-
tion 1 year after cessation [23]. In addition, although sev-
eral similar reports stated that smoking cessation reduced 
the risk of CAD [24, 25], these studies did not investigate 
the association between pack-year and CAD. Furthermore, 
these studies investigated the association between smok-
ing habits and MI or mortality, rather than the severity of 
coronary arteriosclerosis. Our study does not conflict with 
Fig. 2  Association between 
pack-year (a) or duration of ces-
sation (b) and the Gensini score
Fig. 3  Association between 
pack-year (a, b) or duration 
of cessation (c, d) and the 
severity of coronary stenosis 
[the number of significantly 
stenosed coronary vessels (VD) 
and multi-vessel disease (2 + 3 
VD)]. N.S. not significant. 
*p < 0.05 vs. 0 V. #p < 0.05 vs. 
0 + 1 VD
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these previous reports, since the outcome of our study was 
the presence or absence of coronary plaque. For example, 
current smokers are more likely to have lipid-rich plaque 
and OCT-defined vulnerable plaque, while former smok-
ers have more calcified plaque [26], and these results may 
explain the increased risk of acute cardiac events among 
smokers. Although we did not evaluate the quality of 
plaque in our subjects, plaque may be stabilized by the 
improvement of inflammation in blood vessels that results 
from smoking cessation. In this study, we were not able 
to find an association between smoking cessation and the 
severity of coronary arteriosclerosis. Therefore, smoking 
cessation can stabilize the plaque and may decrease coro-
nary events, although smoking cessation dose not regress 
coronary arteriosclerosis.
Low-grade inflammation may exist in smokers and 
inflammation in blood vessels may be improved by 
smoking cessation [27, 28]. CRP has been suggested to 
be a marker of cardiovascular disease risk [29–32]. Sev-
eral studies have reported a positive association between 
smoking and CRP levels [33–37]. Many prospective epi-
demiologic studies have demonstrated that hs-CRP inde-
pendently predicts vascular risk. Furthermore, it has been 
reported that PTX-3 is associated with cardiovascular risk 
factors [38]. In our study, we investigated the association 
between smoking habits and inflammatory markers (hs-
CRP and PTX-3). The current smoking group showed 
significantly lower levels of PTX-3, whereas there were 
no significant differences in the level of hs-CRP, and 
pack-year was not significantly correlated with hs-CRP or 
PTX-3 (data not shown). Thus, current smoking is impor-
tant for its effect on the levels of PTX-3. Since PTX-3 may 
have an atheroprotective role in addition to serving as a 
marker of inflammation [39], smoking might downregu-
late the levels of PTX-3. Further detailed analysis will be 
needed to resolve this issue.
This study has several important limitations. First, the 
study was cross-sectional and included a relatively small 
number of patients. Second, the severity of coronary ath-
erosclerosis by CTA was evaluated after various treatments. 
Third, CTA is not a gold standard for the evaluation of 
CAD, although recent studies have shown that both its sen-
sitivity and specificity were approximately 95 % of those 
for invasive coronary angiography for the identification 
of significant coronary stenosis. Fourth, there was a small 
number of current smokers (n = 56, 13.4 %).
In conclusion, pack-year, but not the duration of ces-
sation, was shown to be the most important factor that is 
associated with the severity of coronary stenosis in terms of 
VD and the Gensini score.
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